Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Neurocrine Bioscienc (NBIX)

52.15 -0.97 (-1.83%)

8/18/2017  4:00pm

Open:

53.00

Pre. Close:

53.12

High:

53.78

Low:

52.07

Volume:

778,086

Market Cap:

4.60B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

54.52 - 55.64

55.64 - 56.44

Low:

49.67 - 50.76

50.76 - 51.53

Close:

50.48 - 52.3

52.3 - 53.59

Technical analysis  (as of: 2017-08-18 4:44:45 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 64.50     One year: 75.33

Support:

Support1: 49.60    Support2: 46.13

Resistance:

Resistance1: 55.22    Resistance2: 64.50

Pivot:

52.26

Moving Averages:

MA(5): 53.37     MA(20): 51.43

MA(100): 48.70     MA(250): 46.75

MACD:

MACD(12,26): 1.55     Signal(12,26,9): 1.59

%K %D:

%K(14,3): 72.26     %D(3): 78.53

RSI:

RSI(14): 56.24

52-Week:

High: 55.38  Low: 37.35  Change(%): 1.2

Average Vol(K):

3-Month: 96014  10-Days 43454

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
NBIX has closed above bottom band by 48.9%. Bollinger Bands are 18.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 16 Aug 2017 15:33:45 GMT
Neurocrine Biosciences: Ingrezza's Strong Launch, Pipeline To Create Value

Fri, 04 Aug 2017 14:48:45 GMT
Neurocrine Biosciences Off To A Good Start With Ingrezza

Fri, 28 Jul 2017 16:52:30 GMT
Neurocrine Biosciences Announces Conference Call and Webcast to Report Second ...

Thu, 16 Feb 2017 16:49:11 GMT
Neurocrine Biosciences Building Toward Bigger Things

Fri, 03 Feb 2017 20:15:00 GMT
The Positive Investment Case For Neurocrine Biosciences

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

88.22

Shares Float (M)

86.76

% Held by Insiders

0.89

% Held by Institutions

98.10

Shares Short (K)

4620

Shares Short Prior Month (K)

8750

Stock Financials

EPS

-2.310

EPS Est. Current Year

-2.450

EPS Est. Next Year

-1.730

EPS Est. Next Quarter

-0.400

Forward EPS

-1.440

Book Value (p.s.)

2.820

PEG Ratio

1.62

Profit Margin

Operating Margin

Return on Assets (ttm)

-34.5

Return on Equity (ttm)

-60.6

Qtrly Rev. Growth

Gross Profit (p.s.)

0.170

Sales Per Share

EBITDA (p.s.)

-2.321

Qtrly Earnings Growth

Operating Cash Flow (M)

-154.33

Levered Free Cash Flow (M)

-85.67

FoxReading.com

Valuation

P/E

-22.58

P/E Growth Ratio

-0.02

P/BV

18.49

P/S

P/CF

-29.81

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

1995-12-29

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.